Non-targeted characterization of attributes affecting antibody-FcγRIIIa V158 (CD16a) binding via online affinity

Daniel W Woodall1, Thomas M Dillon1, Kevin Kalenian1

  • 1Attribute Sciences, Process Development, Amgen Inc, Thousand Oaks, California, USA.

Mabs
|January 3, 2022
PubMed